Table 7.
6-Month Follow-up Reported Risk Reduction Behavior Change as a Result of Talking with Someone from RAP
| PHAs (n=98) | CRs (n=157) | Others (n=102)a | Total (n=367) b | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | p c | |
| Drug use risk reduction | |||||||||
| Cut down on drug use | 63 | (70.8) | 80 | (54.1) | 38 | (43.7) | 183 | (55.0) | .001 |
| Started using rubber tips d | 31 | (83.8) | 49 | (72.1) | 22 | (51.2) | 105 | (67.7) | .005 |
| Drug injection risk reduction: e | |||||||||
| Cut back on syringe sharing | 11 | (57.9) | 13 | (37.1) | 9 | (42.9) | 35 | (44.9) | .338 |
| More selective needle partners | 5 | (29.4) | 5 | (15.2) | 2 | (10.1) | 13 | (18.1) | .271 |
| Cleaned with bleach | 13 | (61.9) | 21 | (51.2) | 15 | (53.6) | 50 | (53.2) | .772 |
| Stopped all syringe sharing | 9 | (47.4) | 7 | (20.6) | 4 | (18.2) | 21 | (26.9) | .060 |
| Stopped sharing cookers | 11 | (57.9) | 8 | (23.5) | 4 | (18.2) | 24 | (30.8) | .011 |
| Sexual risk reduction: f | |||||||||
| Used condoms | 37 | (57.8) | 53 | (52.5) | 24 | (39.3) | 117 | (50.4) | .102 |
| Reduced # of sex partners | 36 | (64.3) | 41 | (42.7) | 21 | (38.9) | 100 | (47.2) | .010 |
| Health promotion: | |||||||||
| Talked to drug users about HIV prevention |
81 | (89.0) | 54 | (38.3) | 20 | (23.5) | 158 | (48.5) | .000 |
| Talked to drug users about other health issues |
78 | (88.6) | 59 | (41.5) | 18 | (20.9) | 157 | (48.3) | .000 |
a
Includes 76 CRs of all untrained PHAs (i.e., those who attended 0–4 training sessions) and 26 PHAs who never started the training; PHAs who attended 1–4 training sessions are excluded from this group.
b
Ten PHAs who attended only 1–4 sessions were included in the follow-up total.
c
Chi-square significance calculated across comparison groups for those who reported each preventive or health promotional behavior.
d
Calculated as percent who smoked crack at follow-up.
e
Calculated as percent who injected drugs at follow-up.
f
Calculated as percent who were sexually active at follow-up.